title: New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
authors.forename: Luis
authors.initials: L
authors.lastname: Pacheco Yáñez
authors.forename: Pablo
authors.initials: P
authors.lastname: Malo
authors.forename: María
authors.initials: M
authors.lastname: Etxebeste
authors.forename: Enrique
authors.initials: E
authors.lastname: Aragües
authors.forename: Juan
authors.initials: J
authors.lastname: Medrano
mesh_terms: D003866:Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D017374:Paroxetine / Q000008:administration & dosage / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000209:etiology* / Q000517:prevention & control*
chemical_list: D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors